← Back to Search

Biomarker Study for Cancer

Verified Trial
N/A
Waitlist Available
Research Sponsored by Audubon Bioscience
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Do you identify as Caucasian/Non-Hispanic?
Are you between the ages of 80-89?
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of once per year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to investigate the different changes in proteins and genes that occur in both diseased and healthy populations. The researchers will look at various biomarkers and diagnostic tools to help in medical research. They

Who is the study for?
This study is for individuals aged 20-39 or 70-79 who identify as Caucasian/Non-Hispanic and are citizens of the US or Canada. Participants should generally be in good health, without any specific medical conditions mentioned.
What is being tested?
The trial is an observational study with no interventions. It aims to discover biomarkers by analyzing a wide range of biological materials like proteins and DNA from both healthy people and those with various diseases.
What are the potential side effects?
Since this is an observational study with no direct interventions, participants will not experience side effects related to treatments. However, there may be minimal risks associated with sample collection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of once per year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of once per year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Enrollment and collection totals for a diverse population of subjects/conditions involved in diseases and in healthy/control populations.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Subjects with various conditionsExperimental Treatment1 Intervention
Subjects that have been diagnosed with a condition of interest such as Diabetes, NASH, Breast Cancer, Endometriosis, or other designated condition.
Group II: HealthyExperimental Treatment1 Intervention
Healthy subjects with no history of chronic disease

Find a Location

Who is running the clinical trial?

Audubon BioscienceLead Sponsor
~6667 spots leftby May 2043
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top